Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Links shared publicly online about this topic.
- 993total visits
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Aricept (donepezil) is used to treat Alzheimer's disease. Includes Aricept side effects, interactions and indications.
View full resource at drugs.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, FDA, Aricept, Pfizer, Eisai
Most Recently Shared on July 27, 2010 at 2:15 am By:
FDA Approves Higher-Dose Aricept (donepezil) 23 mg for the Treatment of Alzheimer's Disease - http://bit.ly/9TBLyE
Advertisement
